Description
+ Include: videos + file sub vtt + pdf, size: GB
+ Target Audience: physicians specializing in: family or general practice, internal medicine, endocrinology, geriatric medicine, lipidology, hypertension
+ Sample video: contact me for sample video
+ Information:
Embark on a journey into the forefront of medical knowledge at the 30th Annual Hypertension, Diabetes, & Dyslipidemia Conference, an immersive three-day experience taking place in the captivating city of Savannah, GA, from June 3-5, 2026. This premier event is tailored for Physicians, Nurse Practitioners, Physician Assistants, and healthcare professionals specializing in Geriatric Medicine, Endocrinology, Lipidology, Hypertension, and those managing patients with Diabetes and/or Hyperlipidemia. Dive into the latest advancements, evidence-based practices, and personalized treatment strategies that promise to elevate patient care and outcomes.
Program Objectives
As a result of this educational activity, participants should be better able to:
- Formulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to hypertension, diabetes, and dyslipidemia.
- Utilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.
- Develop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and/or dyslipidemia that will translate into improved long-term outcomes.
Target Audience
This conference is designed for physicians, nurse practitioners, physician assistants, and other related health care professionals specializing in areas of geriatric medicine, endocrinology, lipidology and/or hypertension along with those managing patients with hypertension, diabetes, and/or hyperlipidemia.
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
WEDNESDAY, June 3, 2026
| Day 1: Focus on Diabetes | ||
| 7:50 am – 8:00 am | Welcome | A. Mullins, CHCP & J. Basile, MD |
| 8:00 am – 8:45 am | Standards of Care in Type 2 Diabetes in 2026 | C. Low Wang, MD |
| 8:45 am – 9:30 am | Diabetes and Metabolic Associated Steatotic Liver Disease (MASLD)-Evaluation and Treatment | C. Wysham, MD |
| 9:30 am – 10:15 am | Navigating GLP-1RA and SGLT2i Use in Your Patients with Diabetes and Obesity | C. Low Wang, MD |
| 10:15 am: BREAK | ||
| 10:30 am – 11:15 am | Weight Management in Those with Diabesity or Atypical Forms of Diabetes in the Adult | C. Wysham, MD |
| 11:15 am – 11:30 am | Questions for the Faculty | C. Low Wang, MD & C. Wysham, MD |
| 11:30 am – 12:45 pm | Cases from the Faculty | C. Low Wang, MD & C. Wysham, MD |
THURSDAY, June 4, 2026
| Day 2: Focus on Hypertension | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day One Review of Key Points | J. Basile, MD |
| 8:00 am – 9:00 am | What’s New in Outpatient Hypertension: Clinical Pearls from the New 2025 HTN Guideline | J. Basile, MD |
| 9:00 am – 9:45 am | MRA’s (Steroidal and Non-Steroidal) and Aldosterone Synthase Inhibitors in Hypertension and Renal Disease | G. Hundemer, MD |
| 9:45 am – 10:30 am | Hypertension in Older Women; Illuminating a Bright Spot | B. Egan, MD |
| 10:30 am: BREAK | ||
| 10:45 am – 11:30 am | Rethinking Primary Aldosteronism | G. Hundemer, MD |
| 11:30 am – 12:15 pm | Reframing Goal BP to Align Patients and Providers on the Target | B. Egan, MD |
| 12:15 pm – 12:30 pm | Questions for the Faculty | J. Basile, MD, G. Hundemer, MD, & B. Egan, MD |
| 12:30 pm: LUNCH BREAK (Working Lunch) | ||
| 12:45 pm – 2:15 pm | Cases in Hypertension | K. Bryant, MD and above faculty |
FRIDAY, June 5, 2026
| Day 3: Focus on Dyslipidemia | ||
| 7:40 am – 7:45 am | Welcome | A. Mullins, CHCP |
| 7:45 am – 8:00 am | Day Two Review of Key Points | J. Basile, MD |
| 8:00 am – 8:45 am | What’s New in the ACC/AHA Cholesterol Guidelines? | M. Blaha, MD |
| 8:45 am – 9:30 am | Applying the 2026 ACC/AHA Cholesterol Guidelines in Practice | R. Dudum, MD |
| 9:30 am – 10:15 am | What’s on the HORIZON with Lp(a): Comparing the Nearly Completed Lp(a) Trials | M. Blaha, MD |
| 10:15 am: BREAK | ||
| 10:30 am – 11:15 am | Making Sense of Non-Statin Lipid-Lowering Therapies: The When and Why to Use Them | R. Dudum, MD |
| 11:15 am – 11:30 am | Questions for the Faculty | M. Blaha, MD & R. Dudum, MD |
| 11:30 am – 12:45 pm | Cases in Lipids | M. Blaha, MD & R. Dudum, MD |
Reviews
There are no reviews yet.